BioMarin Appoints Pharmaceutical Veteran and Former J and J Executive, Liz McKee Anderson, to Board of Directors

SAN RAFAEL, Calif., July 9, 2019 -- (Healthcare Sales & Marketing Network) -- BioMarin Pharmaceutical Inc. (Nasdaq:BMRN), a global leader in providing therapies for rare genetic diseases, today announced the appointment of pharmaceutical veteran and forme... Biopharmaceuticals, Personnel BioMarin Pharmaceutical, valoctocogene roxaparvovec, hemophilia A, gene therapy

Source: HSMN NewsFeed - July 9, 2019 Category: Pharmaceuticals Source Type: news